General Investing >> Money Manager Interviews >> February 17, 2015
Laton Spahr, CFA, serves as Portfolio Manager of Oppenheimer Dividend Opportunity Fund, Oppenheimer Small- & Mid-Cap Value Fund and Oppenheimer Value Fund at OppenheimerFunds. Prior to joining OppenheimerFunds, Mr. Spahr was a senior portfolio manager at Columbia Management Investment Advisors, where he managed value and income strategies across institutional and retail investment channels. During his 12-year tenure at Columbia, he also conducted equity risk management, analyzed and traded derivatives, and structured products, and was a technology analyst. Previously, Mr. Spahr was an equity analyst at Holland Capital Management, a research intern at Friess Associates and a commercial loan officer at Jackson State Bank. Mr. Spahr holds a B.S. in finance with a minor in accounting from the University of Wyoming, and an M.S. in finance, investments and banking as part of the Applied Security Analysis Program at the University of Wisconsin. He is a CFA charterholder. Profile
Eric Hewitt is the Portfolio Manager of Oppenheimer Small Cap Value Fund and Oppenheimer Mid Cap Value Fund at OppenheimerFunds. Prior to joining OppenheimerFunds, Mr. Hewitt was a product manager and customer portfolio manager responsible for multiple value strategies at Columbia Management Investment Advisors. Previously, he was a senior equity analyst at Diamondback/Harbor Watch Capital Management for a multistrategy hedge fund, and focused on mid- and small-cap value stocks in the consumer noncyclical and cyclical sectors and related industrial and financial areas. Before that, Mr. Hewitt was a senior equity analyst and portfolio manager at AllianceBernstein and a bond trader and funding specialist at Lehman Brothers. Mr. Hewitt holds a B.A. in political science and international relations from the University of Wisconsin, and an MBA with a concentration in finance from the University of Minnesota-Carlson School of Management. Profile
Mr. Spahr: Our team left Columbia Management in February of 2013, and we took over the
